Kogenate (BAY14-2222)

DRUG3 trials

Sponsors

Bayer

Conditions

Hematologic DiseaseHemophiliaHemophilia A

Phase 3

BAY14-2222 Continuous Infusion in Surgeries

CompletedNCT00606060

BayerHemophilia

Start: 2004-07-31End: 2005-05-31Updated: 2010-04-13

Phase 4

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

CompletedNCT00586521

BayerHematologic Disease, Hemophilia A

Start: 2006-02-28End: 2008-03-31Updated: 2014-11-03

Unknown Phase

International PMS Study - KOGENATE Bayer

CompletedNCT00864552

BayerHemophilia A

Start: 2002-12-31End: 2005-12-31Updated: 2009-06-30